150 related articles for article (PubMed ID: 37729058)
1. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing.
Ten Hacken E; Gruber M; Hernández-Sánchez M; Hoffmann GB; Baranowski K; Redd RA; Clement K; Livak K; Wu CJ
STAR Protoc; 2023 Dec; 4(4):102165. PubMed ID: 37729058
[TBL] [Abstract][Full Text] [Related]
2. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
[TBL] [Abstract][Full Text] [Related]
3. Protocol for biallelic tagging of an endogenous gene using CRISPR-Cas9 in human cells.
Kong N; Chan YW
STAR Protoc; 2023 May; 4(2):102286. PubMed ID: 37252842
[TBL] [Abstract][Full Text] [Related]
4. Multiplexed CRISPR-Cas9 protocol for large transgene integration into the Schistosoma mansoni genome.
Ittiprasert W; Moescheid MM; Mann VH; Brindley PJ
STAR Protoc; 2024 Mar; 5(1):102886. PubMed ID: 38354082
[TBL] [Abstract][Full Text] [Related]
5. A user-friendly and streamlined protocol for CRISPR/Cas9 genome editing in budding yeast.
Novarina D; Koutsoumpa A; Milias-Argeitis A
STAR Protoc; 2022 Jun; 3(2):101358. PubMed ID: 35712010
[TBL] [Abstract][Full Text] [Related]
6. Protocol for gene characterization in Aspergillus niger using 5S rRNA-CRISPR-Cas9-mediated Tet-on inducible promoter exchange.
Zheng X; Cairns T; Zheng P; Meyer V; Sun J
STAR Protoc; 2022 Dec; 3(4):101838. PubMed ID: 36595926
[TBL] [Abstract][Full Text] [Related]
7. Protocol for CRISPR-Cas9-mediated genome editing to study spermatogenesis in Caenorhabditis elegans.
Wang P; Cao Z; Wang Q; Ma X; Wang N; Chen L; Zhao Y; Miao L
STAR Protoc; 2023 Dec; 4(4):102720. PubMed ID: 37967017
[TBL] [Abstract][Full Text] [Related]
8. Protocol for generating mutant zebrafish using CRISPR-Cas9 followed by quantitative evaluation of vascular formation.
Luo J; Lu C; Wang M; Yang X
STAR Protoc; 2023 Dec; 4(4):102753. PubMed ID: 38041822
[TBL] [Abstract][Full Text] [Related]
9. Exploiting CRISPR/Cas9 to engineer precise segmental deletions in mouse embryonic stem cells.
Elango R; Panday A; Willis NA; Scully R
STAR Protoc; 2022 Sep; 3(3):101551. PubMed ID: 36042887
[TBL] [Abstract][Full Text] [Related]
10. Differentiation and single-cell RNA-seq analyses of human pluripotent-stem-cell-derived renal organoids.
Lian E; Pietrobon A; Stanford WL
STAR Protoc; 2023 May; 4(2):102314. PubMed ID: 37220001
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9-induced gene knockout in zebrafish.
Medishetti R; Balamurugan K; Yadavalli K; Rani R; Sevilimedu A; Challa AK; Parsa K; Chatti K
STAR Protoc; 2022 Dec; 3(4):101779. PubMed ID: 36317180
[TBL] [Abstract][Full Text] [Related]
12. Combined lentiviral- and RNA-mediated CRISPR/Cas9 delivery for efficient and traceable gene editing in human hematopoietic stem and progenitor cells.
Yudovich D; Bäckström A; Schmiderer L; Žemaitis K; Subramaniam A; Larsson J
Sci Rep; 2020 Dec; 10(1):22393. PubMed ID: 33372184
[TBL] [Abstract][Full Text] [Related]
13. Protocol for performing pooled CRISPR-Cas9 loss-of-function screens.
Mathiowetz AJ; Roberts MA; Morgens DW; Olzmann JA; Li Z
STAR Protoc; 2023 Mar; 4(2):102201. PubMed ID: 37000620
[TBL] [Abstract][Full Text] [Related]
14. CRISPR generation of CSF1R-G795A human microglia for robust microglia replacement in a chimeric mouse model.
Chadarevian JP; Davtyan H; Lombroso SI; Bennett FC; Blurton-Jones M
STAR Protoc; 2023 Sep; 4(3):102490. PubMed ID: 37516973
[TBL] [Abstract][Full Text] [Related]
15. Generation of mouse hippocampal neural precursor cell lines with CRISPR/Cas9-mediated gene knockouts.
Zocher S; Kempermann G
STAR Protoc; 2021 Jun; 2(2):100472. PubMed ID: 33948565
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the function of murine quiescent hematopoietic stem cells following non-homologous end joining-based genome editing.
Shiroshita K; Kobayashi H; Takubo K
STAR Protoc; 2023 Jun; 4(2):102347. PubMed ID: 37300828
[TBL] [Abstract][Full Text] [Related]
17. Optimized protocol to generate genome-wide inactivated Cas9-expressing murine T cells.
Laprie-Sentenac M; Cretet-Rodeschini C; Menger L
STAR Protoc; 2023 Mar; 4(1):101922. PubMed ID: 36516053
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9 strategies to insert MS2 stem-loops into endogenous loci in
Hoppe C; Ashe HL
STAR Protoc; 2021 Mar; 2(1):100380. PubMed ID: 33786461
[TBL] [Abstract][Full Text] [Related]
19. Protocol for generation of humanized HCC mouse model and cancer-driver mutations using CRISPR-Cas9.
Zhu Y; Tahara SM; Tsukamoto H; Machida K
STAR Protoc; 2023 Dec; 4(4):102389. PubMed ID: 38103196
[TBL] [Abstract][Full Text] [Related]
20. Optimized protocols for efficient gene editing in mouse hepatocytes
Chen Y; Ding Q
STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
